Search
for

    Sort by

    Research 31–60 of 1000+

    1. Polycystic ovary syndrome — the skin as a mirror of endocrine disorders Forum Dermatologicum · 2026
    2. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Reviews in endocrine and metabolic disorders · 2016 · 41 citations
    3. Animal models of androgen-dependent disorders of the pilosebaceous apparatus Archives of dermatological research · 1989 · 38 citations
    4. Androgen-Dependent Beard Dermal Papilla Cells Secrete Autocrine Growth Factor(s) in Response to Testosterone Unlike Scalp Cells 1998 · 51 citations
    5. Defects in Androgen Biosynthesis Causing 46,XY Disorders of Sexual Development Seminars in reproductive medicine · 2012 · 46 citations
    6. Polymorphisms in androgen and estrogen receptor genes: effects on male aging Experimental Gerontology · 2004 · 12 citations
    7. The Role of Androgens in Health and Disease in Females: A Narratıve Review Anatolian journal of obstetrics and gynecology research. · 2025
    8. Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i> Gynecological Endocrinology · 2000 · 78 citations
    9. Gender aspects in skin diseases Journal of the European Academy of Dermatology and Venereology · 2010 · 48 citations
    10. Obesity and the skin British Journal of Dermatology · 2011 · 128 citations
    11. MENSTRUAL DISORDERS IN ADOLESCENTS Pediatric Clinics of North America · 1999 · 75 citations
    12. Androgens and androgen receptor action in skin and hair follicles Molecular and Cellular Endocrinology · 2017 · 100 citations
    13. Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment Primary Care · 2007 · 21 citations
    14. The 5α-Recluctase System and Its Inhibitors Dermatology · 1996 · 124 citations
    15. Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch European Journal of Pharmaceutics and Biopharmaceutics · 2025
    16. Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles European Journal of Pharmaceutics and Biopharmaceutics · 2007 · 24 citations
    17. Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase The Journal of Steroid Biochemistry and Molecular Biology · 2000 · 11 citations
    18. The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases Advances in Urology · 2011 · 218 citations
    19. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    20. Tissue-Selective Regulation of Androgen-Responsive Genes Endocrine Research · 2012 · 14 citations
    21. Disorders of hair in infants and children other than alopecia Clinics in dermatology · 2002 · 13 citations
    22. The Biology of Hair Growth Elsevier eBooks · 2009 · 10 citations
    23. Alopecia: managing the basics Cambridge University Press eBooks · 2015
    24. Androgens in women Journal of The American Academy of Dermatology · 2018 · 56 citations
    25. Culture of the human pilosebaceous unit, hair follicle and sebaceous gland Experimental Dermatology · 2018 · 30 citations
    26. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms Inflammation Research · 2020 · 82 citations
    27. Endocrine-skin interactions Journal of The American Academy of Dermatology · 1988 · 46 citations
    28. Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women Molecular Medicine Reports · 2016 · 24 citations
    29. Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin? British Journal of Dermatology · 1982 · 14 citations
    30. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial Contraception · 2009 · 42 citations